COLUMBUS, Ohio — Ohio Gov. Mike DeWine signed into law this week a bill that would establish an alert system for residents nearby a convict escaped from custody. When a convicted person escapes ...

SAN FRANCISCO, Dec. 03, 2025 (GLOBE NEWSWIRE) -- DIMERx, Inc. (“DIMERx”), a clinical-stage biopharmaceutical company developing first-in-class dimer-based therapeutics for major public-health needs, ...

CHICAGO — A polar bear born in the Toledo Zoo over a decade ago is preparing for a new adventure. Siku, who was born at the zoo in 2009, will soon leave Chicago's Lincoln Park Zoo for the Henry Vilas ...

Amicus Therapeutics (NASDAQ:FOLD) was upgraded to Buy from Hold at Needham with a $14 target, emphasizing that the company's kidney disease program, DMX-200, is undervalued. The stock of the company ...

Season one of “How Are We Today?” premieres September 15 on Public Television. “How Are We Today?” is an educational TV program for ages 12 and up that provides free education, at-home therapeutic ...

CARBON CLIFF, Ill. — There is a transformation in mental health in Rock Island County. The Phoenix Program is a special education program run by Black Hawk Area Special Education District with Bethany ...

Amicus Therapeutics FOLD reported adjusted earnings of 1 cent per share for the second quarter of 2025, which missed the Zacks Consensus Estimate of 2 cents. The company had incurred a loss of 6 cents ...

SAN DIEGO — San Diego leaders Thursday announced an additional $15 million in funding for the Bridge to Home initiative to aid in the construction of more homes in the city. This marks the sixth round ...

DMX-512 (Digital Multiplex) is the standard protocol used in the entertainment and lighting industry for example to control stage lighting, effects and other devices. It was developed by the ...

SAN FRANCISCO, July 09, 2025 (GLOBE NEWSWIRE) -- DIMERx, Inc., a late-stage clinical biopharmaceutical company developing covalently bonded dimer therapeutics, today announced the appointment of ...

SAN FRANCISCO, June 25, 2025 (GLOBE NEWSWIRE) -- DIMERx, Inc., a late-stage biopharmaceutical company entering growth phase, today announced it has been awarded a UG3/UH3 cooperative agreement ...